NR1H4 and Other metabolic disease: The compartmentalized nature of FXR signaling underscores the importance of developing tissue-targeted FXR modulators for metabolic disorders, as systemic FXR activation or inhibition may produce conflicting physiological effects due to the receptor’s distinct regulatory roles in different organ systems.